The largest database of trusted experimental protocols

Vivoquant 4

Manufactured by Invicro
Sourced in United States

VivoQuant 4.0 is a comprehensive, multimodal image analysis software suite for preclinical imaging data. It provides a platform for visualization, processing, and quantification of multimodal data, including PET, SPECT, CT, MRI, and optical imaging.

Automatically generated - may contain errors

11 protocols using vivoquant 4

1

Rhesus Monkey Brain Region Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The analysis was performed with VivoQuant 4.5 (Invicro, Boston, USA). Based on the structures and regions available in the cortical hierarchy atlas of the rhesus monkey (CHARM) [42 (link)] and the subcortical hierarchy atlas of the rhesus monkey (SARM) [43 (link)] a selection of several regions of interest (ROIs) was made to fuse with the PET–CT data obtained within the study (Additional file 1: Table S1). These ROIs were combined to be able to maintain the general position of the structures towards each other but also to adjust them to the brain of each animal. The fusion and the necessary adjustments are based on both the PET and CT data. Afterwards the standardized uptake values (SUV) of the ROIs were calculated resulting in an average signal of the ROI represented by the SUVmean and an average SUV within a 1-mm3 spherical volume around the voxels with the highest value by the SUVpeak.
+ Open protocol
+ Expand
2

PET-CT Imaging of Pituitary Uptake

Check if the same lab product or an alternative is used in the 5 most similar protocols
Positron emission tomography (PET)-CT data were acquired using a multiscan large field-of-view extreme resolution research imager (LFER) 150 PET-CT (Mediso Medical Imaging Systems Ltd., Budapest, Hungary), as described before [20 (link)]. In brief, animals were fasted overnight to decrease glucose levels below 10 mmoL/L. Sedation was induced IM with ketamine (10 mg/kg) (ketamine hydrochloride; Alfasan Nederland BV, Woerden, The Netherlands), combined with medetomidine hydrochloride (0.05 mg/kg) (Sedastart; AST Farma B.V., Oudewater, The Netherlands), and maintained with isoflurane. Thirty minutes after the IV injection of approximately 100 MBq of 18F-FDG (GE Healthcare, Leiderdorp, The Netherlands), a single field-of-view PET of the head is acquired for 15 min. Data was analyzed in VivoQuant 4.5 (Invicro, Boston, MA, USA). Based on repeatability and parameters for the correct interpretation of the results, a standardized uptake value (SUV) ratio between the pituitary gland and brain was used for robustness. The ratios were calculated for both the average SUV (SUVmean) in a region of interest and maximum average SUV within a 1-mm3 spherical volume SUV (SUVpeak). Threshold levels were defined as SUVmean ratio ≥ 1.5 and SUVpeak ratio ≥ 1.0.
+ Open protocol
+ Expand
3

PET Imaging of Tuberculosis Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
After an incubation period of 12 weeks post-infection, the M. tuberculosis-infected animals were randomly assigned to a treatment group that received a single dose of cisplatin (15 mg/kg, Sigma) intraperitoneally, and a control group that was similarly treated with PBS. Six hours later, the mice received 4.83 ± 0.60 MBq of [18F]-ICMT-11 via tail vein and were imaged within a sealed biocontainment bed (Minerve), as described previously [18 (link)]. Dynamic PET was acquired from 15 to 60 minutes post-injection (nanoScan PET/CT, Mediso) and reconstructed into 5-minute frames. Next, a computed tomography (CT) was acquired for anatomical coregistration. Scatter and attenuation correction were applied to the PET data, which was visualized using VivoQuant 4.0 (Invicro). Quantification of the [18F]-ICMT-11 activity in tissues was performed by drawing volumes of interest (VOIs) on the pulmonary affected areas, based on the CT, using AMIDE 1.0.4. Data for blood activities were obtained by placing a VOI in the left ventricle of the heart. The PET data are expressed as % injected dose (ID) per volume of tissue (mL).
+ Open protocol
+ Expand
4

Quantifying Rifampin Uptake Using PET

Check if the same lab product or an alternative is used in the 5 most similar protocols
The [11C]rifampin PET data were visualized using Mirada XD 3.6 (Mirada Medical) where VOIs were manually drawn using CT as a guide and applied to the dynamic PET data3 (link),4 (link). For cavities, VOIs were drawn to include only the cavity wall, excluding the air in the cavities. PMOD 4.1 (PMOD Technologies) was used to generate time–activity curves for each VOI, represented as a unit of radioactivity (kBq) per ml. Tissue density (X-ray attenuation value (Hounsfield unit)) obtained by CT for each VOI42 was used to correct the corresponding PET VOIs to represent rifampin measurements per mass of tissue. Whole-blood VOIs drawn in the left heart ventricle were corrected to plasma using the individual hematocrit values from each patient. Images were visualized using OsiriX MD 11.0 DICOM Viewer (Pixmeo SARL) and VivoQuant 4.0 (Invicro) for human and rabbit data, respectively. Heat map overlays were implemented using R software (R Foundation for Statistical Computing).
+ Open protocol
+ Expand
5

Quantitative 19F/1H MRI of Liver

Check if the same lab product or an alternative is used in the 5 most similar protocols
Image data were analyzed using VivoQuant 4.0 software (VQ, Invicro, Boston, MA). The 19F/1H RARE images were co-registered using a standard affine transformation. The liver region of interest (ROI) was segmented manually using the 1H image to calculate total liver volume, which was directly mapped to the 19F data to measure the total 19F signal intensity. Signal intensity was calibrated to total number of fluorine atoms using a calibrated reference tube in the image, as described elsewhere [13 (link), 16 (link), 17 (link)]. The 19F data were also normalized to the segmented 1H MRI liver volume to calculate the fluorine content per tissue volume. Using 1H MGE images, liver volumes were manually segmented from all image slices in which the liver was visible using an image from a single echo. Quantification of PDFF [6 (link), 7 (link), 15 (link), 18 (link)] was performed in VQ using a multistep adaptive fitting algorithm that is based on a method previously described by Zhong et al. [18 (link)]. T1 maps were reconstructed using Bruker on-board software. Mean T1 relaxation times were measured directly from liver ROIs manually defined across all liver slices using VQ without correction to separate fat/water.
+ Open protocol
+ Expand
6

In Vivo Biodistribution of Radioisotope-Labeled NM-scFv

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 111In-labeled NM-scFv was IV injected into three mice at a dose of 152.5 µg of siRNA per kg of mouse at 3.7 ± 0.74 MBq of radioactivity. At 40 min post-injection, the mice were sacrificed and SPECT-CT images were acquired with a NanoSPECT/CT (Mediso, Budapest, Hungary). Helical SPECT scans with 24 projections of 60 s were acquired before the CT scans with the following parameters: exposure time at 500 m, 55 KVp, 145 µA, 180 projections and pitch set to 1. The reconstruction of SPECT images was performed on the HiSPECT NG software (Scivis GmbH, Göttingen, Germany) and that of CT images was achieved on InVivoScope software (Invicro, Boston, MA, USA). The accumulation of radioactivity in major organs was also quantified using VivoQuant 4.0 (Invicro, Boston, MA, USA) thanks to a mouse phantom filled with known 111In activity. The final results were presented as mean values ± standard deviation.
+ Open protocol
+ Expand
7

Longitudinal PET/CT Imaging of Tuberculosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three sequential PET/CT scans were performed, using Mediso’s LFER150 PET/CT scanner, at 6, 12, and 18/19 weeks after M. tuberculosis infection with the last scan prior to necropsy. PET/CT scanning was essentially performed as described earlier (66 (link)). Briefly, we performed FDG PET/CT scans for each anesthetized macaque using the breath-hold technique (69 (link), 70 (link)). Animals were anesthetized and intubated under supervision of a veterinarian as per approved IACUC protocols. All the animals received an intravenous injection of 5 mCi of FDG (71 (link)) in the right arm, procured from Cardinal Health radio pharmacy. Single- and a double–field of view CT scans were performed using breath-hold as described (72 (link)). The single–field of view (single-FOV) CT scan was performed with bread-hold as described previously (34 (link)) to obtain a clear reconstructed image of the lung; the 2-FOV scan was used for the reconstruction of the PET as the material map. Two FOV PET scans were acquired after a 45-minute FDG uptake period. Images were visualized using Interview Fusion 3.03 (Mediso) and reconstructed using Nucline nanoScan LFER 1.07 (Mediso) with parameters as described (73 (link)). 3D image analysis was performed using VivoQuant 4.0 (Invicro) (74 (link)) to calculate the SUV in the M. tuberculosis lesions observed in the lung.
+ Open protocol
+ Expand
8

Quantitative PET/MRI Analysis of BAT and WAT

Check if the same lab product or an alternative is used in the 5 most similar protocols
Images were analyzed using VivoQuant 4.0 pre-clinical image post-processing software (Invicro, Boston, MA, USA). PET–MRI raw data were processed using the standard software provided by the manufacturers. PET data were acquired in list mode, histogrammed by Fourier re-binning, and reconstructed using a 3D-OSEM algorithm, with standard corrections for random coincidences, system response, and physical decay applied. The PET/MR scanner-reconstructed PET images were quantitated using a system-specific 18F calibration factor to convert reconstructed count rates per voxel to activity concentrations (%ID/g). Manual tissue segmentation of BAT and automatic segmentation of WAT were performed on co-registered 3D MR images. The regional ROIs were then used to calculate tissue radiotracer uptake from the reconstructed PET images (Figure 6A) [64 (link)].
+ Open protocol
+ Expand
9

Fluorescent Ly6G-Labeled Iron Oxide Nanoparticle Imaging in Lupus

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used iron oxide nanoparticles-neutravidin with fluorescent dye AF647 (10 nm, Catalog No. CM1, NanoparTZ, Loveland, CO, US) to conjugate anti-Ly6G-biotin antibody at a mass ratio of 5:2. This Ly6G-NP was sorted and injected intraperitoneally in lupus mice at a dose of 50 μg/mouse, whereas PBS was used as the negative control. On 28 DPI of pristane, i.e., 24 h after intranasal administration of fluorescent Ly6G-NP (2 μg of antibody conjugated to 5 μg of NP per mouse), the lungs were harvested. The tissue sample was scanned (MOMENTUM, Magnetic Insight, Alameda, CA, USA) with a magnetic field gradient strength of 6 T/m, a detection limitation of 100 nM NP [10 (link)]. Two-dimensional imaging was performed using the following parameters: FOV: 5 × 10 cm; scan mode: isotropic; total time: 2 min. VivoQuant software (VivoQuant 4.0, Invicro, Boston, MA, USA) was used to analyze the images.
+ Open protocol
+ Expand
10

SPECT Imaging Quantification Pipeline

Check if the same lab product or an alternative is used in the 5 most similar protocols
Images were analyzed with VivoQuant 4.0 software (inviCRO, Boston, MA, USA) using a custom script pipeline (available upon request). An arbitrary threshold of 5 SUV was applied to highlight regions of increased uptake on the SPECT images. The stomach, an endogenous site of pertechnetate uptake, was manually removed from the thresholded region. Regions of uptake 64 voxels (1mm3) or greater localized within the liver by the coregistered CT image were included in the final region of interest (ROI), while smaller regions were filtered out to reduce false positives. Total apparent volume of the ROI (VSUV5), number of separate lesions (n), maximum uptake value (SUVmax), and the summed uptake values of each voxel in the ROI (SUVsum) were quantified.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!